Rebecca Lin
Director/Board Member at Shanghai Rarestone Health Tech Group Co. Ltd.
Profile
Rebecca Lin is currently the Director at Shanghai Rarestone Health Tech Group Co. Ltd.
and the Senior Partner at Eight Roads Capital Advisors (CHINA).
She completed her undergraduate degree at Shenzhen University in 1994 and obtained an MBA from The Wharton School of the University of Pennsylvania in 2000.
Rebecca Lin active positions
| Companies | Position | Start |
|---|---|---|
| Eight Roads Capital Advisors (CHINA) | Private Equity Investor | 2020-12-31 |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Director/Board Member | - |
Training of Rebecca Lin
| Shenzhen University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Eight Roads Capital Advisors (CHINA) | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
- Stock Market
- Insiders
- Rebecca Lin
